Medically induced coma is induced in patients with traumatic brain injury who need to cure infection. When doctors use certain drugs, they cause coma. This is an unconscious state in which the body does not feel pain. This is an effective stop of brain activity during trauma surgery.
This report contains market size and forecasts of Medically Induced Coma in Global, including the following market information:
Global Medically Induced Coma Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Medically Induced Coma market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Propofol Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Medically Induced Coma include Astrazeneca, B. Braun Melsungen, Baxter Healthcare Corporation, Dr.Reddy's Laboratories, Fresenious, Hikma Pharmaceuticals, Pfizer, Piramal Healthcare and Teva Pharmaceuticals Industries and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medically Induced Coma companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medically Induced Coma Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Medically Induced Coma Market Segment Percentages, by Type, 2021 (%)
Propofol
Barbiturate
Global Medically Induced Coma Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Medically Induced Coma Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
Global Medically Induced Coma Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Medically Induced Coma Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medically Induced Coma revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Medically Induced Coma revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astrazeneca
B. Braun Melsungen
Baxter Healthcare Corporation
Dr.Reddy's Laboratories
Fresenious
Hikma Pharmaceuticals
Pfizer
Piramal Healthcare
Teva Pharmaceuticals Industries
Viatris